Resolutions for the General Meeting of Shareholders
Annual general meeting of shareholders, 21st fiscal yearElection of 3 directors serving as Audit & Supervisory Committee members
| Item | Details |
|---|---|
| Type of shareholders' meeting | Annual general meeting of shareholders, 21st fiscal year |
| Date and time | 19 June 2026 |
| Matters for resolution | Proposal No. 2: Election of 3 directors serving as Audit & Supervisory Committee members |
| Director nominee | 3 (breakdown between new and outside directors: not disclosed; however, Takahara Shigeki (高原 茂季) is listed as an outside director candidate serving as an Audit & Supervisory Committee Member) |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.ISS recommended voting against the candidate on independence grounds, stating that information had not been disclosed to enable shareholders to assess the significance of the business relationship between the candidate's former employer and the Company. The Company explained that Pfizer Inc. and the Company's group had no business relationship during the most recent 3 fiscal years and that more than 6 years had elapsed since the candidate's retirement, among other reasons, and therefore there were no concerns regarding independence.